Company page
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. is a public company traded under the ticker SPRO in the American market. The company has a market capitalization of approximately $68.9 million. Spero Therapeutics focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- SPRO:NASDAQ
- Asset type
- Stock
- Market cap
- $68.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD